PSMA Antikörper

European patent · EP2360169 · Deleted

Register entry

Publication number
EP2360169
Application number
EP10184957
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Oct 23, 2002
Published
Aug 24, 2011
Granted
Oct 14, 2015
Deleted
Oct 14, 2015
Reason
Revoked in opposition
IPC classes
C07H 21/04 (2006.01)
C12N 5/12 (2006.01)
C07K 16/00 (2006.01)
A61K 39/395 (2006.01)
G01N 33/53 (2006.01)
Priority
US 335215 P 23.10.2001
US 362747 P 07.03.2002
US 412618 P 20.09.2002
Divided from
EP02802198
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 25, 2024

    Change

    Published in Swissreg on 25.06.2024

  2. Jun 15, 2018

    Change

    Published in Swissreg on 15.06.2018

  3. Oct 14, 2015

    Granted

    Published in Swissreg on 14.10.2015

Parties

Holder

Psma Development Company, L.L.C.

Progenics Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, New York 10591, US

Inventor

Maddon, Paul

Scarsdale NY New York 10583, US

Donovan, Gerald

New York NY New York 10021, US

Olson, William

Ossining NY New York 10562, US

Schulke, Norbert

New City NY New York 10956, US

Gardner, Jason

Ardsley NY New York 10502, US

Ma, Dangshe

Millwood NY New York 10546, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.